Parsons Capital Management Inc Edwards Lifesciences Corp Transaction History

Parsons Capital Management Inc

$1.55 Billion
Q3 2024

A detailed history of Parsons Capital Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Parsons Capital Management Inc holds 3,769 shares of EW stock, worth $271,631. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,769

Previous 3,769 -0.0%

Holding current value

$271,631

Previous $348,000 28.74%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$84.3 - $94.31 $5,648 - $6,318	-67 Reduced 1.75%	3,769 $348,000
Q1 2024 Apr 22, 2024	SELL	$72.54 - $95.56 $652 - $860	-9 Reduced 0.23%	3,836 $366,000
Q4 2023 Jan 22, 2024	BUY	$61.71 - $77.76 $740 - $933	12 Added 0.31%	3,845 $293,000
Q3 2023 Nov 06, 2023	BUY	$69.28 - $93.38 $554 - $747	8 Added 0.21%	3,833 $265,000
Q2 2023 Aug 04, 2023	SELL	$81.41 - $94.33 $651 - $754	-8 Reduced 0.21%	3,825 $360,000
Q1 2023 Apr 17, 2023	SELL	$74.26 - $84.51 $8,539 - $9,718	-115 Reduced 2.91%	3,833 $317,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $1,092 - $1,399	16 Added 0.41%	3,948 $294,000
Q3 2022 Oct 26, 2022	BUY	$82.37 - $107.29 $1,894 - $2,467	23 Added 0.59%	3,932 $325,000
Q2 2022 Jul 29, 2022	BUY	$86.5 - $128.27 $4,498 - $6,670	52 Added 1.35%	3,909 $372,000
Q1 2022 May 02, 2022	BUY	$101.96 - $128.34 $9,074 - $11,422	89 Added 2.36%	3,857 $454,000
Q4 2021 Feb 07, 2022	SELL	$106.37 - $130.68 $106 - $130	-1 Reduced 0.03%	3,768 $488,000
Q3 2021 Nov 09, 2021	SELL	$102.91 - $122.75 $823 - $982	-8 Reduced 0.21%	3,769 $427,000
Q2 2021 Aug 03, 2021	BUY	$83.84 - $104.76 $167 - $209	2 Added 0.05%	3,777 $391,000
Q1 2021 Apr 28, 2021	BUY	$78.68 - $90.67 $236 - $272	3 Added 0.08%	3,775 $316,000
Q4 2020 Feb 08, 2021	BUY	$71.69 - $91.23 $71 - $91	1 Added 0.03%	3,772 $344,000
Q3 2020 Oct 29, 2020	BUY	$67.19 - $87.44 $201 - $262	3 Added 0.08%	3,771 $301,000
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $144,540 - $193,298	2,512 Added 200.0%	3,768 $260,000
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $12,840 - $19,845	-245 Reduced 16.32%	1,256 $237,000
Q4 2019 Feb 03, 2020	BUY	$71.7 - $82.09 $14,268 - $16,335	199 Added 15.28%	1,501 $350,000
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $4,800 - $5,883	-78 Reduced 5.65%	1,302 $286,000
Q2 2019 Aug 01, 2019	SELL	$55.74 - $64.41 $55 - $64	-1 Reduced 0.07%	1,380 $255,000
Q1 2019 Apr 26, 2019	BUY	$47.89 - $64.05 $66,136 - $88,453	1,381 New	1,381 $264,000

Others Institutions Holding EW

# of Institutions

1,349

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Account

Parsons Capital Management Inc Edwards Lifesciences Corp Transaction History